Incensus Pharma IvS — Credit Rating and Financial Key Figures
CVR number: 37162949
Bogøvej 15, 8382 Hinnerup
mette.kristensen@wiikpharma.dk
tel: 81614046
Income statement (kDKK)
2016 | 2017 | 2018 | 2019 | 2020 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | |||||
| Gross profit | -1.50 | -1.25 | -1.25 | -1.48 | -1.50 |
| EBIT | -1.50 | -1.25 | -1.25 | -1.48 | -1.50 |
| Other financial expenses | -0.02 | -0.10 | -0.14 | ||
| Pre-tax profit | -1.50 | -1.27 | -1.35 | -1.63 | -1.50 |
| Net earnings | -1.50 | -1.27 | -1.35 | -1.63 | -1.50 |
Assets (kDKK)
2016 | 2017 | 2018 | 2019 | 2020 | |
|---|---|---|---|---|---|
| Intangible assets total | |||||
| Tangible assets total | |||||
| Investments total | |||||
| Long term receivables total | |||||
| Inventories total | |||||
| Short term receivables total | |||||
| Cash and bank deposits | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash and cash equivalents | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Balance sheet total (assets) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Equity and liabilities (kDKK)
2016 | 2017 | 2018 | 2019 | 2020 | |
|---|---|---|---|---|---|
| Share capital | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Retained earnings | -1.50 | -2.77 | -4.12 | -5.75 | |
| Profit of the financial year | -1.50 | -1.27 | -1.35 | -1.63 | -1.50 |
| Shareholders equity total | -1.50 | -2.77 | -4.12 | -5.74 | -7.24 |
| Non-current liabilities total | |||||
| Current trade creditors | 1.50 | 1.50 | 1.50 | 1.50 | 1.50 |
| Current owed to group member | 1.27 | 2.62 | 4.25 | 5.75 | |
| Current liabilities total | 1.50 | 2.77 | 4.12 | 5.75 | 7.25 |
| Balance sheet total (liabilities) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
CreditReports API
- Company information
- Financial data
- Credit risk data
- All 400,000+ Danish companies
Try the full version of our system for free
- Professional credit risk reports
- Create your own estimates for any company
- Valuation analysis
- All 400,000+ Danish companies
- See instructions
... and more!
No registration needed.